Hertzog P J, Robinson H C, Ma J, Mackay I R, Linnane A W
Centre for Molecular Biology and Medicine, Monash University, Clayton, Victoria, Australia.
Int J Cancer. 1991 May 30;48(3):355-63. doi: 10.1002/ijc.2910480308.
A mucin preparation from a colonic adenocarcinoma was used to prepare monoclonal antibodies (MAbs) that reacted specifically either with normal adult small-intestine mucin antigen(s) (SIMA), or normal adult large-intestine mucin antigen(s) (LIMA). Both SIMA and LIMA show a unique oncofetal pattern of expression. Thus SIMA was expressed in early fetal stomach, large and small intestines but thereafter only in the normal small intestine. SIMA expression was detected immunohistochemically in cancers of the colorectum (82/112) and stomach (48/86). LIMA was detected in the stomach of the early fetus but thereafter only in the normal large intestine. LIMA expression was detected in 61/86 cancers of the stomach. Moreover, both SIMA and LIMA were expressed inappropriately in mucosa adjacent to tumors, indicative of the detection of possible pre-malignant epithelium. We used a sandwich ELISA and biochemical procedures to show that the SIMA and LIMA molecules were large extensively glycosylated multi-unit mucin glycoproteins that differed markedly from each other. SIMA, whether extracted from normal small-intestine or colonic cancers, had a molecular weight above 1.000 kDa, a mean buoyant density 1.33 g/ml and s value of 4.8. LIMA had a molecular weight above 10.000 kDa, a mean buoyant density 1.45 g/ml and an s value 9.5. The SIMA and LIMA epitopes were judged to be carbohydrate in nature by reason of their resistance to harsh physical chemical treatments or protease digestion, and sensitivity to periodate oxidation, neuraminidase or beta elimination. Only the SIMA epitope was sensitive to neuraminidase. In conclusion, MAbs to carbohydrate-dependent epitopes on SIMA and LIMA identify the oncofetal pattern of expression of these distinct intestinal mucin glycoproteins in colonic and gastric carcinoma. These MAbs will be useful in further studies of the significance of oncofetal mucin expression during carcinogenesis.
用来自结肠腺癌的粘蛋白制剂制备单克隆抗体(MAb),这些抗体可特异性地与正常成人小肠粘蛋白抗原(SIMA)或正常成人大肠粘蛋白抗原(LIMA)发生反应。SIMA和LIMA均呈现独特的癌胚表达模式。因此,SIMA在胎儿早期的胃、大肠和小肠中表达,但此后仅在正常小肠中表达。免疫组织化学检测发现,SIMA在结直肠癌(82/112)和胃癌(48/86)中表达。LIMA在胎儿早期的胃中被检测到,但此后仅在正常大肠中表达。在86例胃癌中有61例检测到LIMA表达。此外,SIMA和LIMA在肿瘤邻近的黏膜中均出现异常表达,这表明可能检测到了癌前上皮。我们使用夹心ELISA和生化方法表明,SIMA和LIMA分子是大型的、广泛糖基化的多单位粘蛋白糖蛋白,彼此之间有显著差异。SIMA,无论从正常小肠还是结肠癌中提取,分子量均高于1000 kDa,平均浮力密度为1.33 g/ml,沉降系数为4.8。LIMA分子量高于10000 kDa,平均浮力密度为1.45 g/ml,沉降系数为9.5。由于SIMA和LIMA表位对 harsh物理化学处理或蛋白酶消化具有抗性,而对高碘酸盐氧化、神经氨酸酶或β消除敏感,因此判断它们本质上是碳水化合物。只有SIMA表位对神经氨酸酶敏感。总之,针对SIMA和LIMA上碳水化合物依赖性表位的单克隆抗体识别了这些不同肠粘蛋白糖蛋白在结肠癌和胃癌中的癌胚表达模式。这些单克隆抗体将有助于进一步研究癌胚粘蛋白表达在致癌过程中的意义。